Effect of the Size and Shape of Dendronized Iron Oxide Nanoparticles Bearing a Targeting Ligand on MRI, Magnetic Hyperthermia, and Photothermia Properties—From Suspension to In Vitro Studies

Functionalized iron oxide nanoparticles (IONPs) are increasingly being designed as a theranostic nanoplatform combining specific targeting, diagnosis by magnetic resonance imaging (MRI), and multimodal therapy by hyperthermia. The effect of the size and the shape of IONPs is of tremendous importance to develop theranostic nanoobjects displaying efficient MRI contrast agents and hyperthermia agent via the combination of magnetic hyperthermia (MH) and/or photothermia (PTT). Another key parameter is that the amount of accumulation of IONPs in cancerous cells is sufficiently high, which often requires the grafting of specific targeting ligands (TLs). Herein, IONPs with nanoplate and nanocube shapes, which are promising to combine magnetic hyperthermia (MH) and photothermia (PTT), were synthesized by the thermal decomposition method and coated with a designed dendron molecule to ensure their biocompatibility and colloidal stability in suspension. Then, the efficiency of these dendronized IONPs as contrast agents (CAs) for MRI and their ability to heat via MH or PTT were investigated. The 22 nm nanospheres and the 19 nm nanocubes presented the most promising theranostic properties (respectively, r2 = 416 s−1·mM−1, SARMH = 580 W·g−1, SARPTT = 800 W·g−1; and r2 = 407 s−1·mM−1, SARMH = 899 W·g−1, SARPTT = 300 W·g−1). MH experiments have proven that the heating power mainly originates from Brownian relaxation and that SAR values can remain high if IONPs are prealigned with a magnet. This raises hope that heating will maintain efficient even in a confined environment, such as in cells or in tumors. Preliminary in vitro MH and PTT experiments have shown the promising effect of the cubic shaped IONPs, even though the experiments should be repeated with an improved set-up. Finally, the grafting of a specific peptide (P22) as a TL for head and neck cancers (HNCs) has shown the positive impact of the TL to enhance IONP accumulation in cells.

[1]  S. Laurent,et al.  Bioconjugation studies of an EGF-R targeting ligand on dendronized iron oxide nanoparticles to target head and neck cancer cells. , 2023, International journal of pharmaceutics.

[2]  C. M. Lucaciu,et al.  Enhanced Magnetic Hyperthermia Performance of Zinc Ferrite Nanoparticles under a Parallel and a Transverse Bias DC Magnetic Field , 2022, Nanomaterials.

[3]  L. Motte,et al.  Iron Oxide Nanoparticles Functionalized with Fucoidan: a Potential Theranostic Nanotool for Hepatocellular Carcinoma , 2022, Chembiochem : a European journal of chemical biology.

[4]  F. Banhart,et al.  A Confinement-Driven Nucleation Mechanism of Metal Oxide Nanoparticles Obtained via Thermal Decomposition in Organic Media. , 2022, Small.

[5]  E. Chan,et al.  Stimuli-controllable iron oxide nanoparticle assemblies: Design, manipulation and bio-applications. , 2022, Journal of controlled release : official journal of the Controlled Release Society.

[6]  W. Stummer,et al.  Combined Fluorescence-Guided Resection and Intracavitary Thermotherapy with Superparamagnetic Iron-Oxide Nanoparticles for Recurrent High-Grade Glioma: Case Series with Emphasis on Complication Management , 2022, Cancers.

[7]  C. Wilhelm,et al.  Structure-Property-Function Relationships of Iron Oxide Multicore Nanoflowers in Magnetic Hyperthermia and Photothermia. , 2021, ACS nano.

[8]  A. Fay,et al.  Intercomparison of radiosensitization induced by gold and iron oxide nanoparticles in human glioblastoma cells irradiated by 6 MV photons , 2021, Scientific Reports.

[9]  M. Kurihara,et al.  Size-tunable synthesis of iron oxide nanocrystals by continuous seed-mediated growth: role of alkylamine species in the stepwise thermal decomposition of iron(II) oxalate. , 2021, Dalton transactions.

[10]  G. Salas,et al.  Assessing the parameters modulating optical losses of iron oxide nanoparticles under near infrared irradiation , 2021, Nanoscale advances.

[11]  S. Laurent,et al.  Unveiling the role of surface, size, shape and defects of iron oxide nanoparticles for theranostic applications. , 2021, Nanoscale.

[12]  R. Costo,et al.  Time-dependent AC magnetometry and chain formation in magnetite: the influence of particle size, initial temperature and the shortening of the relaxation time by the applied field , 2021, Nanoscale advances.

[13]  S. Cianférani,et al.  Iron Stearate Structures: An Original Tool for Nanoparticles Design. , 2021, Inorganic chemistry.

[14]  R. Canese,et al.  Iron Oxide Nanoparticles as Theranostic Agents in Cancer Immunotherapy , 2021, Nanomaterials.

[15]  M. Geppert,et al.  Iron Oxide Nanoparticles in Bioimaging – An Immune Perspective , 2021, Frontiers in Immunology.

[16]  C. Petit,et al.  Harnessing Composition of Iron Oxide Nanoparticle: Impact of Solvent-Mediated Ligand–Ligand Interaction and Competition between Oxidation and Growth Kinetics , 2020 .

[17]  M. Rols,et al.  Comparison of Iron Oxide Nanoparticles in Photothermia and Magnetic Hyperthermia: Effects of Clustering and Silica Encapsulation on Nanoparticles’ Heating Yield , 2020, Applied Sciences.

[18]  D. Ihiawakrim,et al.  Quantitative Analysis of the Specific Absorption Rate Dependence on the Magnetic Field Strength in ZnxFe3−xO4 Nanoparticles , 2020, International journal of molecular sciences.

[19]  M. Ibarra,et al.  Low-Dimensional Assemblies of Magnetic MnFe2O4 Nanoparticles and Direct In Vitro Measurements of Enhanced Heating Driven by Dipolar Interactions: Implications for Magnetic Hyperthermia , 2020, 2011.07500.

[20]  C. Wilhelm,et al.  Iron Oxide Mediated Photothermal Therapy in the Second Biological Window: A Comparative Study between Magnetite/Maghemite Nanospheres and Nanoflowers , 2020, Nanomaterials.

[21]  Jyh-Ping Chen,et al.  Optimization of the Preparation of Magnetic Liposomes for the Combined Use of Magnetic Hyperthermia and Photothermia in Dual Magneto-Photothermal Cancer Therapy , 2020, International journal of molecular sciences.

[22]  G. Știufiuc,et al.  Saturation of Specific Absorption Rate for Soft and Hard Spinel Ferrite Nanoparticles Synthesized by Polyol Process , 2020, Magnetochemistry.

[23]  M. García-Martín,et al.  Magnetic Nanoparticles as MRI Contrast Agents , 2020, Topics in Current Chemistry.

[24]  M. Lattuada,et al.  Characterization of the Shape Anisotropy of Superparamagnetic Iron Oxide Nanoparticles during Thermal Decomposition , 2020, Materials.

[25]  E. M. Castanheira,et al.  Shape Anisotropic Iron Oxide-Based Magnetic Nanoparticles: Synthesis and Biomedical Applications , 2020, International journal of molecular sciences.

[26]  S. Tofail,et al.  MRI Guided Magneto-chemotherapy with High-Magnetic-Moment Iron Oxide Nanoparticles for Cancer Theranostics. , 2020, ACS applied bio materials.

[27]  L. Liz‐Marzán,et al.  Janus Magnetic-Plasmonic Nanoparticles for Magnetically Guided and Thermally Activated Cancer Therapy. , 2020, Small.

[28]  Xing-jie Liang,et al.  Comprehensive understanding of magnetic hyperthermia for improving antitumor therapeutic efficacy , 2020, Theranostics.

[29]  M. Taheri,et al.  Surface modification of superparamagnetic iron oxide (SPION) and comparison of cytotoxicity effect of mPEG2000-PEI-SPION and mPEG750-PEI-SPION on the human embryonic carcinoma stem cell, NTERA2 cell line. , 2020, Human antibodies.

[30]  T. Etrych,et al.  Targeted Polymer-Based Probes for Fluorescence Guided Visualization and Potential Surgery of EGFR-Positive Head-and-Neck Tumors , 2020, Pharmaceutics.

[31]  Françis Perton Architecture de nanoparticules hybrides pour une imagerie et/ou thérapie multimodales , 2019 .

[32]  A. Scherberich,et al.  Metronidazole-functionalized iron oxide nanoparticles for molecular detection of hypoxic tissues. , 2019, Nanoscale.

[33]  T. Pellegrino,et al.  Confining iron oxide nanocubes inside submicrometric cavities as a key strategy to preserve magnetic heat losses in an intracellular environment. , 2019, ACS applied materials & interfaces.

[34]  T. Clauditz,et al.  Analyzing expression and phosphorylation of the EGF receptor in HNSCC , 2019, Scientific Reports.

[35]  S. Laurent,et al.  Dendron based antifouling, MRI and magnetic hyperthermia properties of different shaped iron oxide nanoparticles , 2019, Nanotechnology.

[36]  C. Sangregorio,et al.  Precise Size Control of the Growth of Fe3O4 Nanocubes Over a Wide Size Range Using a Rationally Designed One-Pot Synthesis. , 2019, ACS nano.

[37]  E. Alphandéry Biodistribution and targeting properties of iron oxide nanoparticles for treatments of cancer and iron anemia disease , 2019, Nanotoxicology.

[38]  K. Kaur,et al.  Small Peptide Ligands for Targeting EGFR in Triple Negative Breast Cancer Cells , 2019, Scientific Reports.

[39]  Hao Zhang,et al.  Iron oxide nanoparticles promote the migration of mesenchymal stem cells to injury sites , 2019, International journal of nanomedicine.

[40]  T. Pellegrino,et al.  Thermoresponsive Iron Oxide Nanocubes for an Effective Clinical Translation of Magnetic Hyperthermia and Heat-Mediated Chemotherapy , 2019, ACS applied materials & interfaces.

[41]  Seyed Mohammadali Dadfar,et al.  Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications , 2019, Advanced drug delivery reviews.

[42]  S. Veintemillas-Verdaguer,et al.  Design strategies for shape‐controlled magnetic iron oxide nanoparticles , 2019, Advanced drug delivery reviews.

[43]  F. Ludwig,et al.  Fe2+ Deficiencies, FeO Subdomains, and Structural Defects Favor Magnetic Hyperthermia Performance of Iron Oxide Nanocubes into Intracellular Environment. , 2018, Nano letters.

[44]  D. Ihiawakrim,et al.  Unravelling the Thermal Decomposition Parameters for The Synthesis of Anisotropic Iron Oxide Nanoparticles , 2018, Nanomaterials.

[45]  A. Garanina,et al.  Biodistribution and Tumors MRI Contrast Enhancement of Magnetic Nanocubes, Nanoclusters, and Nanorods in Multiple Mice Models , 2018, Contrast media & molecular imaging.

[46]  E. Golemis,et al.  Molecular Determinants of Head and Neck Cancer , 2018, Current Cancer Research.

[47]  M. Kavallaris,et al.  Biologically Targeted Magnetic Hyperthermia: Potential and Limitations , 2018, Front. Pharmacol..

[48]  L. Liz‐Marzán,et al.  Magnetic (Hyper)Thermia or Photothermia? Progressive Comparison of Iron Oxide and Gold Nanoparticles Heating in Water, in Cells, and In Vivo , 2018, Advanced Functional Materials.

[49]  C. Wilhelm,et al.  Targeted thermal therapy with genetically engineered magnetite magnetosomes@RGD: Photothermia is far more efficient than magnetic hyperthermia , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[50]  Xiao-Dan Sun,et al.  Shape-, size- and structure-controlled synthesis and biocompatibility of iron oxide nanoparticles for magnetic theranostics , 2018, Theranostics.

[51]  C. Flask,et al.  A novel synthetic route for high-index faceted iron oxide concave nanocubes with high T2 relaxivity for in vivo MRI applications , 2018, Journal of Materials Science: Materials in Medicine.

[52]  C. Roberts,et al.  The role of dipole interactions in hyperthermia heating colloidal clusters of densely-packed superparamagnetic nanoparticles , 2018, Scientific Reports.

[53]  Raluca M. Fratila,et al.  RGD-Functionalized Fe3O4 nanoparticles for magnetic hyperthermia. , 2018, Colloids and surfaces. B, Biointerfaces.

[54]  Taeghwan Hyeon,et al.  Recent Development of Inorganic Nanoparticles for Biomedical Imaging , 2018, ACS central science.

[55]  S. Laurent,et al.  How a grafting anchor tailors the cellular uptake and in vivo fate of dendronized iron oxide nanoparticles. , 2017, Journal of materials chemistry. B.

[56]  G. Cowin,et al.  Molecular imaging of activated platelets via antibody-targeted ultra-small iron oxide nanoparticles displaying unique dual MRI contrast. , 2017, Biomaterials.

[57]  C. Wilhelm,et al.  Maghemite nanoparticles coated with human serum albumin: combining targeting by the iron-acquisition pathway and potential in photothermal therapies. , 2017, Journal of materials chemistry. B.

[58]  F. Meyer,et al.  Effect of the Functionalization Process on the Colloidal, Magnetic Resonance Imaging, and Bioelimination Properties of Mono- or Bisphosphonate-Anchored Dendronized Iron Oxide Nanoparticles. , 2017, ChemPlusChem.

[59]  T. Samaras,et al.  Arrangement at the nanoscale: Effect on magnetic particle hyperthermia , 2016, Scientific Reports.

[60]  Damien Mertz,et al.  Design of iron oxide-based nanoparticles for MRI and magnetic hyperthermia. , 2016, Nanomedicine.

[61]  G. Salas,et al.  Effects of inter- and intra-aggregate magnetic dipolar interactions on the magnetic heating efficiency of iron oxide nanoparticles. , 2016, Physical chemistry chemical physics : PCCP.

[62]  Jelena Kolosnjaj-Tabi,et al.  Duality of Iron Oxide Nanoparticles in Cancer Therapy: Amplification of Heating Efficiency by Magnetic Hyperthermia and Photothermal Bimodal Treatment. , 2016, ACS nano.

[63]  S. Laurent,et al.  Validation of a dendron concept to tune colloidal stability, MRI relaxivity and bioelimination of functional nanoparticles. , 2015, Journal of materials chemistry. B.

[64]  Q. Pankhurst,et al.  High performance multi-core iron oxide nanoparticles for magnetic hyperthermia: microwave synthesis, and the role of core-to-core interactions. , 2015, Nanoscale.

[65]  R. Knecht,et al.  The inhibition of PARP but not EGFR results in the radiosensitization of HPV/p16-positive HNSCC cell lines. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[66]  L. Lartigue,et al.  Mastering the Shape and Composition of Dendronized Iron Oxide Nanoparticles To Tailor Magnetic Resonance Imaging and Hyperthermia , 2014 .

[67]  J. Montaner,et al.  Rapid synthesis of water-dispersible superparamagnetic iron oxide nanoparticles by a microwave-assisted route for safe labeling of endothelial progenitor cells. , 2014, Acta Biomaterialia.

[68]  D. Baldomir,et al.  Multiplying Magnetic Hyperthermia Response by Nanoparticle Assembling , 2014 .

[69]  J. Greneche,et al.  Magnetic Iron Oxide Nanoparticles: Reproducible Tuning of the Size and Nanosized-Dependent Composition, Defects, and Spin Canting , 2014 .

[70]  Fuxiang Zhang,et al.  Highly crystallized iron oxide nanoparticles as effective and biodegradable mediators for photothermal cancer therapy. , 2014, Journal of materials chemistry. B.

[71]  L. Bergström,et al.  Anomalous magnetic properties of nanoparticles arising from defect structures: topotaxial oxidation of Fe(1-x)O|Fe(3-δ)O4 core|shell nanocubes to single-phase particles. , 2013, ACS nano.

[72]  M. Botta,et al.  Scaling Laws at the Nano Size: The Effect of Particle Size and Shape on the Magnetism and Relaxivity of Iron Oxide Nanoparticle Contrast Agents. , 2013, Journal of materials chemistry. B.

[73]  Francesca Peiró,et al.  Learning from Nature to Improve the Heat Generation of Iron-Oxide Nanoparticles for Magnetic Hyperthermia Applications , 2013, Scientific Reports.

[74]  M. A. García,et al.  Colloidal Ordered Assemblies in a Polymer Shell—A Novel Type of Magnetic Nanobeads for Theranostic Applications , 2013 .

[75]  J. Bacri,et al.  Cooperative organization in iron oxide multi-core nanoparticles potentiates their efficiency as heating mediators and MRI contrast agents. , 2012, ACS nano.

[76]  P. Leedman,et al.  Regulation of Epidermal Growth Factor Receptor Signaling and Erlotinib Sensitivity in Head and Neck Cancer Cells by miR-7 , 2012, PloS one.

[77]  Liberato Manna,et al.  Water-soluble iron oxide nanocubes with high values of specific absorption rate for cancer cell hyperthermia treatment. , 2012, ACS nano.

[78]  Hauke Kloust,et al.  Relaxivity optimization of a PEGylated iron-oxide-based negative magnetic resonance contrast agent for T₂-weighted spin-echo imaging. , 2012, ACS nano.

[79]  Hakho Lee,et al.  Highly magnetic core-shell nanoparticles with a unique magnetization mechanism. , 2011, Angewandte Chemie.

[80]  C. Ulhaq,et al.  Microstructural and Magnetic Investigations of Wüstite-Spinel Core-Shell Cubic-Shaped Nanoparticles , 2011 .

[81]  M. Vázquez,et al.  Magnetic Iron Oxide Nanoparticles in 10−40 nm Range: Composition in Terms of Magnetite/Maghemite Ratio and Effect on the Magnetic Properties , 2011 .

[82]  Sophie Laurent,et al.  How to quantify iron in an aqueous or biological matrix: a technical note. , 2009, Contrast media & molecular imaging.

[83]  E. Golemis,et al.  Targeting EGFR resistance networks in head and neck cancer. , 2009, Cellular signalling.

[84]  J. Greneche,et al.  Coupling Agent Effect on Magnetic Properties of Functionalized Magnetite-Based Nanoparticles , 2008 .

[85]  Armel Le Bail,et al.  Ab-initio structure determination of LiSbWO6 by X-ray powder diffraction , 1988 .

[86]  Daniel Horák,et al.  Size-dependent magnetic properties of iron oxide nanoparticles , 2016 .

[87]  J. Vermorken,et al.  Targeting the ErbB family in head and neck cancer , 2007 .

[88]  P. Harari,et al.  EGFR-targeting monoclonal antibodies in head and neck cancer. , 2006, Current cancer drug targets.

[89]  Juan Rodriguez-Carvaj,et al.  Recent advances in magnetic structure determination neutron powder diffraction , 1993 .